eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
10-Q

Quarterly report which provides a continuing view of a company's financial position

Quarterly Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
DEF 14A

Official notification to shareholders of matters to be brought to a vote ("Proxy")

Proxy Filings
DEFA14A

Additional proxy soliciting materials - definitive

Proxy Filings
4

Statement of changes in beneficial ownership of securities

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
PRE 14A

A preliminary proxy statement providing notification matters to be brought to a vote

Proxy Filings
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5
3

Initial filing by director officer or owner of more than ten percent.

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]